Searched for
GENERIC HEALTH PTY LTD
Stocks in news: Adani Enterprises, Tata Motors PV, Tata Steel, Jio Financial, ITC HotelsMarkets extended their rebound for a second consecutive session on Thursday, buoyed by supportive global cues and selective buying in heavy...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- India Pharma 2026 event: Nadda lays out road map for India to take global pharma leadership roleIndia Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- Lupin gains on USFDA nod to market Sevelamer CarbonateAccording to data for September 2021 released by IQVIA MAT September, Sevelamer Carbonate for oral suspension had estimated annual sales of...
- Lupin acquires Australia's Southern Cross PharmaAs a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of o...
- Lupin to acquire Australia-based Southern Cross PharmaGeneric Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquir...
- Lupin to launch nearly 30 products in US market in FY18The drug firm is banking on the introduction of complex generics and biosimilars in the US to maintain its top five position in the market.
- PM Narendra Modi's push for generic drugs to shift focus to chemists, says pharma industry bodyPatients may end up with drugs that "may not be effective at all" if doctors were made to prescribe only generic medicines,, according to p...
- PM Narendra Modi hints at rules for doctors to prescribe generic drugs“We will bring in a legal framework by which if a doctor writes a prescription, he has to write in it that it will be enough for patients t...
- Indian-origin brothers caught up in UK pharma scandal: ReportThe investigation claims that Atnahs, a company the brothers set up in 2013, specialises in buying the rights to older medications that are...
- Pharma exports up 9.7 per cent, 33 per cent growth in US markets in FY16Generic drugs form the largest segment, with 75 per cent of market share (in terms of revenues), of the Indian pharmaceutical sector.
- Soon, doctors to write prescriptions in capital lettersFear of misinterpretation due to doctor's illegible handwriting may soon be a thing of the past as government is set to make it a norm for ...
- Aurobindo Pharma rallies nearly 3% on USFDA nod for hypertension drugAt 09:40 a.m.; Aurobindo Pharma was trading 1.7 per cent higher at Rs 1107. It hit a low of Rs 1102.20 and a high of Rs 1118.50 in trade to...
- FDI policy in pharmaceuticals sector set for major overhaulThe changes to be brought will prospective in nature, the official said, adding the current policy was not serving its objectives.
- Free medicines for all at public health facilities soonHealth Ministry is aiming to roll out its ambitious project for provision of free medicines to all at public health facilities across the c...
- Lupin eyes $150 mn from oral contraceptives in US by FY14Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin acquires Australian brand GoannaThe company said its sales and marketing efforts will commence immediately since Goanna is an in-market commercial product.
- Lupin acquires global rights for Australian brand GoannaLupin said it has acquired the worldwide rights for Australian brand Goanna from Aspen Pharmacare Holdings for an undisclosed amount.
- Rising income and awareness will drive pharma growth: CIIThe Rs 36,000 crore Indian pharmaceutical market is likely to grow at 19.4 per cent on the back of rising health consciousness and increasi...
Load More
